Jobs

About the role


In this new role you will be supporting the successful delivery of multidisciplinary projects through coordination with project stakeholders both internally and externally, monitoring progress of project activities, identifying risks within project plans and helping solve challenges.


You will work as part of the clinical team and engage with multiple teams across the company, including innovation, data science, product development and engineering.

Department : Human Tissue / Neuroanatomy


About Cerevance:

Overview:

The aim of the post is to strategically expand Queen Mary University of London’s provision of Degree Apprenticeships. The post holder will work with academic departments to identify potential degree apprenticeship programmes, liaise with employers who might be interested in becoming partners in existing and co-developed Degree Apprenticeships, draft proposals for Degree Apprenticeship programmes and support the development of new Degree Apprenticeship ‘standards’.

Overview:

Apprenticeship Providers are required to abide by the Education and Skills Funding Agency annual funding rules and the terms and conditions of the official Register of Apprenticeship Training Providers. From April 2021, Ofsted will also assume responsibility for auditing the quality of degree level provision.

We are looking for an experienced, proactive and highly-organised Equality, Diversity and Inclusion (EDI) Programme Manager to support our EDI Team to deliver an ambitious and progressive programme of activity, including progressing and elevating our equality charter marks, such as Athena SWAN, Stonewall, Race at Work and Disability Confident.


sanger.ac.uk/about/equality-in-science/


About the role:

With an expanding small molecule drug discovery portfolio Artios Pharma is recruiting for an experienced cell and molecular biologist. This is an excellent opportunity to join a world class research team in a dynamic, small Biotech company based south of Cambridge, UK. Artios is focused on identifying and developing cancer treatments by exploiting novel targets within the DNA damage response (DDR), a scientific area of high expectation following the success of PARP inhibitors in the clinic. The company is actively working on an exciting portfolio of unique DNA repair projects.

With an expanding small molecule drug discovery portfolio Artios Pharma is recruiting for a biochemistry and screening scientist. This is an excellent opportunity to join a world class research team in a dynamic, small Biotech company based south of Cambridge, UK. Artios is focused on identifying and developing cancer treatments by exploiting novel targets within the DNA damage response (DDR), a scientific area of high expectation following the success of PARP inhibitors in the clinic. The company is actively working on an exciting portfolio of unique DNA repair projects.

With an expanding small molecule drug discovery portfolio, Artios Pharma is recruiting for an experienced in vivo pharmacologist . This is an excellent opportunity to join a world class research team in a dynamic, small Biotech company based south of Cambridge, UK. Artios is focused on identifying and developing cancer treatments by exploiting novel targets within the DNA damage response (DDR), a scientific area of high expectation following the success of PARP inhibitors in the clinic. The company is actively working on an exciting portfolio of unique DNA repair projects.

Maxion Therapeutics is a newly formed biotechnology company focused on developing antibody-like therapeutics to address unmet medical needs. The company uses their innovative KnotBody technology® in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCRs. Maxion cultivates a dynamic and innovative environment for its employees driven by its scientific founders who are pioneers in the field of antibody engineering.

Sense is a rapidly growing venture-capital backed company that has developed an entirely new class of diagnostic product – an instrument-free molecular test. The Company’s VEROS™ products combine the superior performance of laboratory testing with the proven market benefits of disposable tests. Sense has ambitious plans to grow from its strong foundations and become a global leader in this exciting new segment of the diagnostics industry.

Pages